Researchers examined the epidemiology of hydroxymethylbilane synthase (HMBS) gene defects and activity levels among patients with acute intermittent porphyria to better understand the role of HMBS activity...
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
New research reveals that elevated serum neurofilament light chain levels correlate with both acute and chronic neurological damage in acute hepatic porphyria, offering clinicians a potential tool for...
